{
    "clinical_study": {
        "@rank": "82481", 
        "arm_group": {
            "arm_group_label": "osteoprosis research"
        }, 
        "biospec_descr": {
            "textblock": "Basal whole blood is collected for serum and DNA extraction."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "To popularize knowledge of prevention and health care of osteoporosis.To investigate the\n      prevalence of primary osteoporosis in community residents."
        }, 
        "brief_title": "Longitudinal Study of Primary Osteoporosis in Shanghai Postmenopausal Women", 
        "completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Primary Osteoporosis", 
        "condition_browse": {
            "mesh_term": "Osteoporosis"
        }, 
        "detailed_description": {
            "textblock": "1. Objective:\n\n             -  To popularize knowledge of prevention and health care of osteoporosis.\n\n             -  To investigate the prevalence of primary osteoporosis in community residents.\n\n        2. Method:\n\n             -  The survey study included the five boroughs of six communities in Shanghai (Xuhui\n                District 2, Pudong New Area 1, Minhang District 1, Pudong New Area 1, Jiading\n                District 1). 10,000 participants are expected to be included.\n\n             -  Through a questionnaire and physical examination form, carries on the\n                investigation to the 50-85 years old postmenopausal women during the 3-year\n                follow-up period.\n\n             -  Make a survey of Bone Mineral Density,SF-36,international osteoporosis foundation\n                ONE-MINUTE OSTEOPOROSIS RISK TEST,Markers of bone metabolism\n                test,EQ-5D,Hepatic-renal function test and thyroid stimulating hormone level test.\n\n             -  Physicians in each community as the backbone, Shanghai University of Traditional\n                Chinese Medicine, Longhua Hospital is responsible for personnel training.\n\n             -  Shanghai Clinical Research Center is responsible for program and data management.\n\n             -  Shanghai District Health and Family Planning Commission is responsible for\n                coordinating the organization."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Had clinical diagnosis of osteoporosis.\n\n          -  With Bone Mineral Density by dual energy X-ray examination, T value <-2.5 or less.\n\n          -  Be willing to and be able to join in the study and signed Informed consent.\n\n        Exclusion Criteria:\n\n          -  Excluding the impact of endocrine diseases of bone metabolism (gonadal, adrenal,\n             parathyroid and thyroid disease), rheumatoid arthritis and other autoimmune diseases\n             that affect the absorption of calcium and vitamin D and regulation of the digestive\n             tract and kidney disease, multiple myeloma and other malignant diseases, long-term\n             use of corticosteroids or other drugs affecting bone metabolism, and a variety of\n             congenital and acquired diseases of bone metabolism.\n\n          -  if they were unable to complete the study survey."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Randomly selected two communities in Xuhui District to investigate."
            }
        }, 
        "enrollment": {
            "#text": "3000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02142348", 
            "org_study_id": "Shanghai OP Survey"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 15, 2014", 
        "location": {
            "contact": {
                "email": "13917715524@139.com", 
                "last_name": "Xuejun Cui"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "200032"
                }, 
                "name": "Longhua Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Chenguang Li, Dr.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Jing Wang, master", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "official_title": "Longitudinal Study of Primary Osteoporosis in Shanghai Postmenopausal Women", 
        "overall_contact": {
            "email": "13917715524@139.com", 
            "last_name": "Xuejun Cui, Dr."
        }, 
        "overall_official": {
            "affiliation": "Study Principal Investigator Longhua Hospital", 
            "last_name": "Yongjun Wang, Dr", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Science and Technology Commission of Shanghai Municipality", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Bone Mineral Density", 
            "safety_issue": "No", 
            "time_frame": "baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02142348"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shanghai University of Traditional Chinese Medicine", 
            "investigator_full_name": "Cui xuejun", 
            "investigator_title": "Vice director", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "a composite of functional status", 
                "measure": "SF-36", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }, 
            {
                "measure": "international osteoporosis foundation ONE-MINUTE OSTEOPOROSIS RISK TEST", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }, 
            {
                "description": "Fasting peripheral blood collected 2ml.Markers of bone metabolism test\uff0cincluding  alkaline phosphatase, 25-hydroxy-vitamin D\uff0cprepeptide type\u2160 procollagen\uff0costeocalcin\uff0ctype I collagen cross-linked C-terminal telopeptide\uff0ctartrate resistant acid phosphatase.", 
                "measure": "Markers of bone metabolism test", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }, 
            {
                "description": "A standardised instrument for use as a measure of health outcome.", 
                "measure": "EQ-5D", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }, 
            {
                "description": "Fasting peripheral blood collected 2ml.Hepatic-renal function test\uff0cincluding calcium, phosphorus, creatinine.", 
                "measure": "Hepatic-renal function test", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }, 
            {
                "description": "Fasting peripheral blood collected 1ml for thyroid stimulating hormone test.", 
                "measure": "thyroid stimulating hormone level test", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }
        ], 
        "source": "Shanghai University of Traditional Chinese Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shanghai University of Traditional Chinese Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}